Clinical Trial Update: Phase II Clinical Trial of Interleukin-2 in AD [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating interleukin-2 for Alzheimer’s disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Alzheimer Disease | Phase 2 | Status: RECRUITING